Japan Radiopharmaceutical Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Radiopharmaceutical market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Radiopharmaceutical market. Detailed analysis of key players, along with key growth strategies adopted by Radiopharmaceutical industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • IBA Group

    • Mallinckrodt

    • Bracco Imaging

    • Jubilant Pharma

    • Bayer

    • GE Healthcare

    • Navidea

    • Lantheus

    • SIEMENS

    • Triad Isotopes

    • Nordion

    • Eli Lilly


    By Type:

    • Therapeutic Radioisotopes

    • Diagnostic Radioisotopes


    By End-User:

    • Cardiology

    • Oncology

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceutical Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

      • 1.3.2 Japan Radiopharmaceutical Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.2 Japan Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.3 Japan Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Radiopharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radiopharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Therapeutic Radioisotopes

      • 3.4.2 Market Size and Growth Rate of Diagnostic Radioisotopes


    4 Segmentation of Radiopharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radiopharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Radiopharmaceutical in Cardiology

      • 4.4.2 Market Size and Growth Rate of Radiopharmaceutical in Oncology

      • 4.4.3 Market Size and Growth Rate of Radiopharmaceutical in Others


    5 Market Analysis by Regions

    • 5.1 Japan Radiopharmaceutical Production Analysis by Regions

    • 5.2 Japan Radiopharmaceutical Consumption Analysis by Regions


    6 Hokkaido Radiopharmaceutical Landscape Analysis

    • 6.1 Hokkaido Radiopharmaceutical Landscape Analysis by Major Types

    • 6.2 Hokkaido Radiopharmaceutical Landscape Analysis by Major End-Users


    7 Tohoku Radiopharmaceutical Landscape Analysis

    • 7.1 Tohoku Radiopharmaceutical Landscape Analysis by Major Types

    • 7.2 Tohoku Radiopharmaceutical Landscape Analysis by Major End-Users


    8 Kanto Radiopharmaceutical Landscape Analysis

    • 8.1 Kanto Radiopharmaceutical Landscape Analysis by Major Types

    • 8.2 Kanto Radiopharmaceutical Landscape Analysis by Major End-Users


    9 Chubu Radiopharmaceutical Landscape Analysis

    • 9.1 Chubu Radiopharmaceutical Landscape Analysis by Major Types

    • 9.2 Chubu Radiopharmaceutical Landscape Analysis by Major End-Users


    10 Kinki Radiopharmaceutical Landscape Analysis

    • 10.1 Kinki Radiopharmaceutical Landscape Analysis by Major Types

    • 10.2 Kinki Radiopharmaceutical Landscape Analysis by Major End-Users


    11 Chugoku Radiopharmaceutical Landscape Analysis

    • 11.1 Chugoku Radiopharmaceutical Landscape Analysis by Major Types

    • 11.2 Chugoku Radiopharmaceutical Landscape Analysis by Major End-Users


    12 Shikoku Radiopharmaceutical Landscape Analysis

    • 12.1 Shikoku Radiopharmaceutical Landscape Analysis by Major Types

    • 12.2 Shikoku Radiopharmaceutical Landscape Analysis by Major End-Users


    13 Kyushu Radiopharmaceutical Landscape Analysis

    • 13.1 Kyushu Radiopharmaceutical Landscape Analysis by Major Types

    • 13.2 Kyushu Radiopharmaceutical Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 IBA Group

      • 14.1.1 IBA Group Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Mallinckrodt

      • 14.2.1 Mallinckrodt Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Bracco Imaging

      • 14.3.1 Bracco Imaging Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Jubilant Pharma

      • 14.4.1 Jubilant Pharma Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Bayer

      • 14.5.1 Bayer Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 GE Healthcare

      • 14.6.1 GE Healthcare Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Navidea

      • 14.7.1 Navidea Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Lantheus

      • 14.8.1 Lantheus Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 SIEMENS

      • 14.9.1 SIEMENS Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Triad Isotopes

      • 14.10.1 Triad Isotopes Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Nordion

      • 14.11.1 Nordion Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Eli Lilly

      • 14.12.1 Eli Lilly Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 92 Figures and 120 Tables)

     

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Radiopharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Radiopharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radiopharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Radiopharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Radiopharmaceutical Production by Regions

    • Table Japan Radiopharmaceutical Production Share by Regions

    • Figure Japan Radiopharmaceutical Production Share by Regions in 2014

    • Figure Japan Radiopharmaceutical Production Share by Regions in 2018

    • Figure Japan Radiopharmaceutical Production Share by Regions in 2026

    • Table Japan Radiopharmaceutical Consumption by Regions

    • Table Japan Radiopharmaceutical Consumption Share by Regions

    • Figure Japan Radiopharmaceutical Consumption Share by Regions in 2014

    • Figure Japan Radiopharmaceutical Consumption Share by Regions in 2018

    • Figure Japan Radiopharmaceutical Consumption Share by Regions in 2026

    • Table Hokkaido Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Hokkaido Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Hokkaido Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Hokkaido Radiopharmaceutical Consumption Share by Types in 2026

    • Table Hokkaido Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Hokkaido Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Hokkaido Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Tohoku Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Tohoku Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Tohoku Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Tohoku Radiopharmaceutical Consumption Share by Types in 2026

    • Table Tohoku Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Tohoku Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Tohoku Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Tohoku Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Kanto Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Kanto Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Kanto Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Kanto Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Kanto Radiopharmaceutical Consumption Share by Types in 2026

    • Table Kanto Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Kanto Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Kanto Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Kanto Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Chubu Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Chubu Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Chubu Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Chubu Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Chubu Radiopharmaceutical Consumption Share by Types in 2026

    • Table Chubu Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Chubu Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Chubu Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Chubu Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Kinki Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Kinki Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Kinki Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Kinki Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Kinki Radiopharmaceutical Consumption Share by Types in 2026

    • Table Kinki Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Kinki Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Kinki Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Kinki Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Chugoku Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Chugoku Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Chugoku Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Chugoku Radiopharmaceutical Consumption Share by Types in 2026

    • Table Chugoku Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Chugoku Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Chugoku Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Chugoku Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Shikoku Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Shikoku Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Shikoku Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Shikoku Radiopharmaceutical Consumption Share by Types in 2026

    • Table Shikoku Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Shikoku Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Shikoku Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Shikoku Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Kyushu Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Kyushu Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Kyushu Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Kyushu Radiopharmaceutical Consumption Share by Types in 2026

    • Table Kyushu Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Kyushu Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Kyushu Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Kyushu Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.